Search research articles
Contact Us
Filters
Showing results (31-40 of 182) with videos related to
Page
of 19
Sort By:
Seminars in Hematology
|
March 31, 2010
Rituximab: therapeutic benefit! Vitamin R?
Clifton Mo, Berengere Vire, Adrian Wiestner
The Lancet. Haematology
|
April 3, 2021
COVID-19 vaccines for patients with haematological conditions
Clare Sun, Christopher Pleyer, Adrian Wiestner
Seminars in Oncology
|
April 5, 2016
Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade
Sarah E M Herman, Adrian Wiestner
Journal of Immunology (Baltimore, Md. : 1950)
|
September 13, 2011
TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation
Bérengère Vire, Alexandre David, Adrian Wiestner
International Journal of Molecular Sciences
|
December 22, 2019
Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
Maissa Mhibik, Adrian Wiestner, Clare Sun
Leukemia & Lymphoma
|
May 17, 2018
Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia
Christopher Pleyer, Adrian Wiestner, Clare Sun
Leukemia & Lymphoma
|
February 20, 2025
Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy
Christine Gruessner, Adrian Wiestner, Clare Sun
Blood
|
October 14, 2010
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
Patricia Pérez-Galán, Martin Dreyling, Adrian Wiestner
Seminars in Cancer Biology
|
September 28, 2011
New molecular targets in mantle cell lymphoma
Samir Parekh, Marc A Weniger, Adrian Wiestner
Mediterranean Journal of Hematology and Infectious Diseases
|
November 22, 2012
Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
Dimitar G Efremov, Adrian Wiestner, Luca Laurenti
Page
of 19
Search research articles
Search
Showing results (31-40 of 182) with videos related to
Sort By:
Page
of 19
Seminars in Hematology
|
March 31, 2010
Rituximab: therapeutic benefit! Vitamin R?
Clifton Mo, Berengere Vire, Adrian Wiestner
The Lancet. Haematology
|
April 3, 2021
COVID-19 vaccines for patients with haematological conditions
Clare Sun, Christopher Pleyer, Adrian Wiestner
Seminars in Oncology
|
April 5, 2016
Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade
Sarah E M Herman, Adrian Wiestner
Journal of Immunology (Baltimore, Md. : 1950)
|
September 13, 2011
TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation
Bérengère Vire, Alexandre David, Adrian Wiestner
International Journal of Molecular Sciences
|
December 22, 2019
Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
Maissa Mhibik, Adrian Wiestner, Clare Sun
Leukemia & Lymphoma
|
May 17, 2018
Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia
Christopher Pleyer, Adrian Wiestner, Clare Sun
Leukemia & Lymphoma
|
February 20, 2025
Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy
Christine Gruessner, Adrian Wiestner, Clare Sun
Blood
|
October 14, 2010
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era
Patricia Pérez-Galán, Martin Dreyling, Adrian Wiestner
Seminars in Cancer Biology
|
September 28, 2011
New molecular targets in mantle cell lymphoma
Samir Parekh, Marc A Weniger, Adrian Wiestner
Mediterranean Journal of Hematology and Infectious Diseases
|
November 22, 2012
Novel Agents and Emerging Strategies for Targeting the B-Cell Receptor Pathway in CLL
Dimitar G Efremov, Adrian Wiestner, Luca Laurenti
Page
of 19